Lilly's Omvoh shows sustained remission in Crohn's disease study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MCD
7. MGM
8. NVDA
9. COST
10. ACAD

Go back to Lilly's Omvoh shows sustained remission in Crohn's disease study
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1181.89 +30.90 (2.68%)
Previous Close $1150.99    52 Week High $88.16 
Open $1156.67    52 Week Low $67.88 
Day High $1197.79    P/E 273.59 
Day Low $1151.00    EPS $4.32 
Volume 2,418,055